We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Aclaris Therapeutics is the latest pharma on the hot seat with the FDA’s promotion enforcers. In this case, the Office of Prescription Drug Promotion is targeting a DTC video it deems misleading.